Terry Rosen

2.2k total citations
31 papers, 1.8k citations indexed

About

Terry Rosen is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Terry Rosen has authored 31 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Organic Chemistry and 7 papers in Pharmacology. Recurrent topics in Terry Rosen's work include Cancer therapeutics and mechanisms (7 papers), Receptor Mechanisms and Signaling (6 papers) and Neuropeptides and Animal Physiology (5 papers). Terry Rosen is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Receptor Mechanisms and Signaling (6 papers) and Neuropeptides and Animal Physiology (5 papers). Terry Rosen collaborates with scholars based in United States, United Kingdom and Japan. Terry Rosen's co-authors include Clayton H. Heathcock, Daniel T. W. Chu, Isabella M. Lico, André G. Pernet, Linus L. Shen, Stafford McLean, Padam N. Sharma, Dongyang Chu, Tayanah O’Donnell and Curt S. Cooper and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Biochemistry.

In The Last Decade

Terry Rosen

31 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Terry Rosen United States 23 1.1k 811 349 317 156 31 1.8k
Kenneth G. Holden United States 22 1.4k 1.3× 668 0.8× 264 0.8× 202 0.6× 557 3.6× 46 2.1k
Wayne E. Childers United States 20 1.1k 1.0× 1.2k 1.4× 384 1.1× 193 0.6× 281 1.8× 73 2.4k
W. Stephen Faraci United States 18 752 0.7× 275 0.3× 299 0.9× 146 0.5× 108 0.7× 25 1.3k
Nancy N. Tsou United States 25 784 0.7× 1.4k 1.7× 440 1.3× 180 0.6× 73 0.5× 49 2.1k
Michael P. Hedrick United States 23 1.3k 1.2× 689 0.8× 540 1.5× 324 1.0× 389 2.5× 35 2.2k
Kak‐Shan Shia Taiwan 25 640 0.6× 1.1k 1.3× 282 0.8× 91 0.3× 184 1.2× 99 2.1k
M. Soriano-Garcı́a Mexico 20 778 0.7× 384 0.5× 80 0.2× 72 0.2× 157 1.0× 176 1.8k
Hideaki Natsugari Japan 28 808 0.8× 1.1k 1.4× 252 0.7× 192 0.6× 125 0.8× 121 2.1k
Steven H. Olson United States 24 669 0.6× 545 0.7× 221 0.6× 133 0.4× 179 1.1× 47 1.7k
Pierfausto Seneci Italy 24 1.2k 1.1× 706 0.9× 167 0.5× 94 0.3× 147 0.9× 109 2.0k

Countries citing papers authored by Terry Rosen

Since Specialization
Citations

This map shows the geographic impact of Terry Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry Rosen more than expected).

Fields of papers citing papers by Terry Rosen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry Rosen. The network helps show where Terry Rosen may publish in the future.

Co-authorship network of co-authors of Terry Rosen

This figure shows the co-authorship network connecting the top 25 collaborators of Terry Rosen. A scholar is included among the top collaborators of Terry Rosen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terry Rosen. Terry Rosen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Medina, Julio C., Daniel Roche, Bei Shan, et al.. (1999). Novel halogenated sulfonamides inhibit the growth of multidrug resistant MCF-7/ADR cancer cells. Bioorganic & Medicinal Chemistry Letters. 9(13). 1843–1846. 72 indexed citations
2.
Rosen, Terry, Karen J. Coffman, Stafford McLean, et al.. (1998). Synthesis and structure-activity relationships of CP-122,721, a second-generation NK-1 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 8(3). 281–284. 28 indexed citations
3.
McLean, Stafford, Alan H. Ganong, Patricia A. Seymour, et al.. (1996). Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptor.. Journal of Pharmacology and Experimental Therapeutics. 277(2). 900–908. 64 indexed citations
4.
McLean, Stafford, R. Michael Snider, Manoj C. Desai, et al.. (1993). CP-99,994, a nonpeptide antagonist of the tachykinin NK1 receptor. Regulatory Peptides. 46(1-2). 329–331. 29 indexed citations
5.
6.
McLean, Stafford, Alan H. Ganong, P A Seymour, et al.. (1993). Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.. Journal of Pharmacology and Experimental Therapeutics. 267(1). 472–479. 205 indexed citations
7.
8.
Rosen, Terry. (1990). 6 The Fluoroquinolone Antibacterial Agents. Progress in medicinal chemistry. 27. 235–295. 25 indexed citations
9.
Rizzi, James P., A. Nagel, Terry Rosen, Stafford McLean, & Thomas Seeger. (1990). An initial three-component pharmacophore for specific serotonin-3 receptor ligands. Journal of Medicinal Chemistry. 33(10). 2721–2725. 40 indexed citations
10.
Rosen, Terry, A. Nagel, Jeffrey L. Ives, et al.. (1990). Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists. Journal of Medicinal Chemistry. 33(10). 2715–2720. 29 indexed citations
11.
Nagel, A., Terry Rosen, James P. Rizzi, et al.. (1990). Aromatic thiazole derivatives: structurally novel and selective serotonin-3 receptor antagonists. Journal of Medicinal Chemistry. 33(1). 13–16. 35 indexed citations
12.
Rosen, Terry, Thomas Seeger, Stafford McLean, et al.. (1990). Synthesis, in vitro binding profile, and CNS penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazole. Journal of Medicinal Chemistry. 33(11). 3020–3023. 5 indexed citations
13.
Rosen, Terry, Prabhavathi Fernandes, Mary Marovich, et al.. (1989). Aromatic dienoyl tetramic acids. Novel antibacterial agents with activity against anaerobes and staphylococci. Journal of Medicinal Chemistry. 32(5). 1062–1069. 29 indexed citations
14.
Shen, Linus L., Lester A. Mitscher, Padam N. Sharma, et al.. (1989). Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding model. Biochemistry. 28(9). 3886–3894. 360 indexed citations
15.
16.
Rosen, Terry, Daniel T. W. Chu, Isabella M. Lico, et al.. (1988). Design, synthesis, and properties of (4S)-7-(4-amino-2-substituted-pyrrolidin-1-yl)quinolone-3-carboxylic acids. Journal of Medicinal Chemistry. 31(8). 1598–1611. 47 indexed citations
17.
Heathcock, Clayton H., et al.. (1987). Total synthesis and biological evaluation of structural analogs of compactin and dihydromevinolin. Journal of Medicinal Chemistry. 30(10). 1858–1873. 31 indexed citations
18.
Rosen, Terry & Clayton H. Heathcock. (1986). The synthesis of mevinic acids. Tetrahedron. 42(18). 4909–4951. 85 indexed citations
19.
Heathcock, Clayton H., Esa T. Jarvi, & Terry Rosen. (1984). Acyclic stereoselection. 21. Synthesis of an ionophore synthon having four asymmetric carbons by sequential aldol addition, claisen rearrangement and hydroboration. Tetrahedron Letters. 25(3). 243–246. 19 indexed citations
20.
Rosen, Terry, et al.. (1984). A convenient assay for the optical purity of monomethyl 3-hydroxypentanedioate. The Journal of Organic Chemistry. 49(19). 3657–3659. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth G. Holden Breakdown of academic impact, for papers by Wayne E. Childers Breakdown of academic impact, for papers by W. Stephen Faraci Breakdown of academic impact, for papers by Nancy N. Tsou Breakdown of academic impact, for papers by Michael P. Hedrick Breakdown of academic impact, for papers by Kak‐Shan Shia Breakdown of academic impact, for papers by M. Soriano-Garcı́a Breakdown of academic impact, for papers by Hideaki Natsugari Breakdown of academic impact, for papers by Steven H. Olson Breakdown of academic impact, for papers by Pierfausto Seneci
Rankless by CCL
2026